NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
8
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/16/2025
Trademark type
Combined
Nice classes
5, 42, 45
Filing date
06/21/2021
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/06/2020
First use in commerce
08/06/2020
Drawing code
3
Owner type
03
Owner location
New York, NY
Examiner
SALCIDO, JOHN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the number "8" with the Greek letters for Gamma and Delta within the center of the top circle with sixteen shaded circles varying in size to the right of the Greek letters and three horizontal lines within the center of the bottom circle.
Holders and representatives
Holders
IN8bio, Inc.
Representatives
Mark A. Jansen FENWICK & WEST LLP
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparationsoncological preparations; reagentdiagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression
Class 42
researchdevelopmentevaluation of new products; pharmaceuticalmedicinevaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; designdevelopmentresearchconducting clinical trials for others in connection with drugspharmaceuticalscellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncologyimmunotherapychemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncologyimmunotherapychemotherapy and combination therapies; scientific advisory servicesproviding scientific informationadvice and consultancy in the field of oncology
Class 45
development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/25/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/25/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/07/2025
IUAF
USE AMENDMENT FILED
12/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2024
EX5G
SOU EXTENSION 5 GRANTED
06/21/2024
EXT5
SOU EXTENSION 5 FILED
06/21/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/19/2023
EX4G
SOU EXTENSION 4 GRANTED
12/15/2023
EXT4
SOU EXTENSION 4 FILED
12/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2023
EX3G
SOU EXTENSION 3 GRANTED
06/26/2023
EXT3
SOU EXTENSION 3 FILED
06/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/26/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/12/2022
EX2G
SOU EXTENSION 2 GRANTED
11/10/2022
EXT2
SOU EXTENSION 2 FILED
11/10/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/24/2022
EX1G
SOU EXTENSION 1 GRANTED
06/22/2022
EXT1
SOU EXTENSION 1 FILED
06/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/22/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/28/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2021
PUBO
PUBLISHED FOR OPPOSITION
11/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/05/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2021
DOCK
ASSIGNED TO EXAMINER
09/27/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2021
NWAP
NEW APPLICATION ENTERED
06/24/2021
Continuous trademark protection
Get notified about every new filing that threatens 8 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.